RS
Roger Song Jefferies Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
United Therapeutics
UTHR
$17.2B
| $380.47 | $564 |
48%
upside
| Buy | 2 days ago |
|
|
ATYR
2
aTyr Pharma
ATYR
$536M
| $5.47 | $17 |
211%
upside
| Buy | 13 days ago |
|
|
MBX
3
MBX Biosciences, Inc. Common Stock
MBX
$434M
| $12.92 | $36 |
179%
upside
| Buy | 20 days ago |
|
4
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $35.51 | $54 |
52%
upside
| Buy | 1 month ago |
|
5
Replimune Group
REPL
$454M
| $5.81 | $6 |
3%
upside
| Buy | 1 month ago |
|
6
CureVac
CVAC
$1.2B
| $5.35 | $5 |
7%
downside
| Hold | 2 months ago |
|
7
Nektar Therapeutics
NKTR
$684M
| $35.98 | $30 |
17%
downside
| Buy | 4 months ago |
|
8
Akebia Therapeutics
AKBA
$801M
| $3.02 | $6 |
99%
upside
| Buy | 5 months ago |
|
9
Sana Biotechnology
SANA
$757M
| $2.98 | $7 |
135%
upside
| Buy | 5 months ago |
|
10
Krystal Biotech
KRYS
$4.33B
| $149.75 | $245 |
64%
upside
| Buy | 6 months ago |
|
11
Wave Life Sciences
WVE
$1.3B
| $8.18 | $26 |
218%
upside
| Buy | 6 months ago |
|
12
Kura Oncology
KURA
$706M
| $8.13 | $28 |
244%
upside
| Buy | 9 months ago |
|
13
Disc Medicine
IRON
$2.09B
| $60.19 | $89 |
48%
upside
| Buy | 10 months ago |
|
14
Novavax
NVAX
$1.27B
| $7.79 | $25 |
221%
upside
| Buy | 10 months ago |
|
15
Nurix Therapeutics
NRIX
$697M
| $9.12 | $41 |
350%
upside
| Buy | 10 months ago |
|
|
ZBIO
16
Zenas BioPharma, Inc. Common Stock
ZBIO
$715M
| $16.98 | $35 |
106%
upside
| Buy | 11 months ago |
|
17
Vaxcyte
PCVX
$4.17B
| $32.15 | $129 |
301%
upside
| Buy | 1 year ago |
|
18
CytomX Therapeutics
CTMX
$346M
| $2.10 | $8 |
281%
upside
| Buy | 1 year ago |
|
19
Nuvalent
NUVL
$5.74B
| $79.67 | $97 |
22%
upside
| Buy | 1 year ago |
|
20
Tourmaline Bio
TRML
$645M
| $25.10 | $72 |
187%
upside
| Buy | 1 year ago |
|
21
Viking Therapeutics
VKTX
$2.98B
| $26.53 | $110 |
315%
upside
| Buy | 1 year ago |
|
22
Altimmune
ALT
$314M
| $3.56 | $35 |
883%
upside
| Buy | 3 years ago |
|
23
Corvus Pharmaceuticals
CRVS
$427M
| $5.73 | $8 |
40%
upside
| Buy | 3 years ago |
|